Dr. Andreas Vente

Managing Director, Co-founder

Therapeutic Areas

Drug	Indication	Phase
Xtoro™ (finafloxacin otic suspension)	Acute Otitis Externa (AOE)	Approved
Systemic Finafloxacin	Complicated Urinary Tract Infections (cUTI) / Pyelonephritis	Phase 2